Your browser doesn't support javascript.
loading
Bevacizumab Combined with Docetaxel or Paclitaxel as First-line Treatment of HER2-negative Metastatic Breast Cancer.
Tiainen, Leena; Tanner, Minna; Lahdenperä, Outi; Vihinen, Pia; Jukkola, Arja; Karihtala, Peeter; Paunu, Niina; Huttunen, Teppo; Kellokumpu-Lehtinen, Pirkko-Liisa.
Afiliación
  • Tiainen L; Department of Oncology, School of Medicine, University of Tampere, Tampere, Finland leena.tiainen@pshp.fi.
  • Tanner M; Department of Oncology, Tampere University Hospital, Tampere, Finland.
  • Lahdenperä O; Department of Oncology, School of Medicine, University of Tampere, Tampere, Finland.
  • Vihinen P; Department of Oncology, Tampere University Hospital, Tampere, Finland.
  • Jukkola A; Department of Oncology, Turku University Central Hospital, Turku, Finland.
  • Karihtala P; Department of Oncology, Turku University Central Hospital, Turku, Finland.
  • Paunu N; Department of Oncology and Radiotherapy, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland.
  • Huttunen T; Department of Oncology and Radiotherapy, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland.
  • Kellokumpu-Lehtinen PL; Department of Oncology, Tampere University Hospital, Tampere, Finland.
Anticancer Res ; 36(12): 6431-6438, 2016 12.
Article en En | MEDLINE | ID: mdl-27919965
Asunto(s)
Palabras clave
Buscar en Google
Añadir a Mi BVS
Imprimir
XML
PubMed Links

Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Anticancer Res Año: 2016 Tipo del documento: Article País de afiliación: Finlandia
Buscar en Google
Añadir a Mi BVS
Imprimir
XML
PubMed Links

Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Anticancer Res Año: 2016 Tipo del documento: Article País de afiliación: Finlandia